Position in ABBV
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$2,463,555
+$297,573 QoQ
Shares Held
9,790
-1.7% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.39%
of 13F equity value
Holder Rank
#1,799
of 4,153 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in ABBV Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Truvestments Capital LLC holds $19,966,308 across 13 Drug Manufacturers - General names. ABBV ranks #4 (12.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
26,544 | $6,741,379 | |
| 2 | BMY |
Bristol Myers Squibb Co
|
60,684 | $3,496,612 | |
| 3 | MRK |
Merck & Co., Inc.
|
25,027 | $3,215,969 | |
| 4 | ABBV |
AbbVie Inc.
This page
|
9,790 | $2,463,555 | |
| 5 | LLY |
ELI LILLY & Co
|
1,330 | $1,595,242 | |
| 6 | PFE |
Pfizer Inc
|
42,672 | $1,027,541 | |
| 7 | AMGN |
Amgen Inc
|
2,481 | $898,419 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
2,234 | $282,243 |
All Filings in ABBV
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,463,555 | 9,790 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $2,165,982 | 9,959 | Shares | Sole | 2026-05-13 | |
| 2025-12-31 | $2,252,454 | 9,858 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $2,370,738 | 10,239 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $2,421,041 | 13,043 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $2,891,795 | 13,802 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,118,908 | 23,179 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $4,309,211 | 21,821 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $3,385,633 | 19,739 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $3,555,502 | 19,525 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $2,046,843 | 13,208 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,748,026 | 11,727 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $1,513,961 | 11,237 | Shares | Sole | 2023-08-10 | |
| 2023-03-31 | $1,642,945 | 10,309 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $1,874,837 | 11,601 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $3,116,490 | 23,221 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $3,397,088 | 22,180 | Shares | Sole | 2022-08-09 | |
| 2022-03-31 | $3,563,826 | 21,984 | Shares | Sole | 2022-05-02 | |
| 2021-12-31 | $2,977,716 | 21,992 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $2,318,881 | 21,497 | Shares | Sole | 2021-10-29 | |
| 2021-06-30 | $2,324,889 | 20,640 | Shares | Sole | 2021-08-12 | |
| 2021-03-31 | $2,101,957 | 19,423 | Shares | Sole | 2021-05-18 | |
| 2020-12-31 | $1,854,336 | 17,306 | Shares | Sole | 2021-02-17 | |
| 2020-09-30 | $1,454,694 | 16,608 | Shares | Other | 2020-11-13 | |
| 2020-06-30 | $1,898,604 | 19,338 | Shares | Sole | 2020-08-06 | |
| 2020-03-31 | $1,617,437 | 21,229 | Shares | Sole | 2020-05-07 | |
| No filing history on record for this holder in this stock. | ||||||